GlassScriptPhysician profile
Brian Thomas Torgerson
NPI 1194928283
$13,121.68
in general payments reported to CMS, 2019-2025
38 companies · $1,008 in 2025
The $1,008 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,604 · 2020: $650 · 2021: $595 · 2022: $906 · 2023: $6,112 · 2024: $1,247 · 2025: $1,008.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $5,158 · Food and Beverage: $3,209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $5,157.88 |
| Food and Beverage | $3,208.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $7,038.20 | 2019-2024 | Omnia, Senza |
| Vertiflex, INC. | $1,358.99 | 2019 | |
| Boston Scientific Corporation | $1,023.05 | 2019-2025 | Intracept, Superion Indirect Decompression System, Wavewriter Alpha Prime 16 |
| Collegium Pharmaceutical, INC. | $565.58 | 2019-2025 | Belbuca |
| Abbott Laboratories | $337.66 | 2019-2023 | Proclaim |
| Medtronic, INC. | $272.82 | 2021-2025 | Intellis Adaptivestim, Accurian |
| Scilex Pharmaceuticals INC. | $232.09 | 2020-2023 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $205.65 | 2019-2025 | Relistor |
| Averitas Pharma INC. | $197.56 | 2023-2025 | Qutenza |
| Allergan, INC. | $194.44 | 2019 | |
| Abbvie INC. | $193.12 | 2021-2025 | Botox |
| Si-Bone, INC. | $191.04 | 2019-2024 | |
| Saluda Medical Americas, INC. | $157.07 | 2023-2024 | Evoke, Evoke Scs |
| Forte Bio-Pharma LLC | $138.71 | 2023-2025 | Prolate, Nalocet, Tanlor |
| Pacira Therapeutics, INC. | $123.12 | 2019-2020 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $120.73 | 2019-2022 | |
| Pfizer INC. | $70.77 | 2019-2021 | |
| Nalu Medical, INC. | $65.13 | 2024-2025 | Nalu Neurostimulation System |
| Grt US Holding, INC. | $64.58 | 2020-2022 | |
| Globus Medical, INC. | $63.65 | 2025 | Senza |
| Horizon Therapeutics Plc | $55.25 | 2019-2022 | |
| Valinor Pharma, LLC | $53.32 | 2025 | Movantik |
| Biodelivery Sciences International, INC. | $49.90 | 2019-2020 | |
| Medtronic USA, INC. | $48.53 | 2019-2020 | |
| Zyla Life Sciences, INC. | $35.72 | 2019-2020 | |
| Spr Therapeutics, INC | $35.17 | 2024-2025 | Sprint Pns System |
| Bioventus LLC | $33.56 | 2021-2025 | Gelsyn-3 |
| Eisai INC. | $32.86 | 2021 | |
| Biogen, INC. | $26.44 | 2023 | Spinraza |
| Zimvie INC. | $21.48 | 2023 | |
| Stryker Corporation | $18.64 | 2025 | Mild Device Kit |
| Ultragenyx Pharmaceutical INC. | $17.91 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $17.58 | 2025 | |
| Azurity Pharmaceuticals, INC. | $16.32 | 2023 | Horizant |
| Medline Industries LP | $14.21 | 2022 | |
| Mdd US Operations, LLC | $11.97 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $10.40 | 2019 | |
| Spinal Simplicity, LLC | $8.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Torgerson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.